Inventor
SORENSEN BRYAN K
US35 patents
⚠️ This page may combine multiple inventors who share the name “SORENSEN BRYAN K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
17 patentsUS6583180B2Jun 24, 2003
Glucocorticoid receptor modulators
ABBOTT LAB80 citations97
US6162927ADec 19, 2000
Endothelin antagonists
ABBOTT LAB46 citations96
US5767144AJun 16, 1998
Endothelin antagonists
ABBOTT LAB90 citations96
US7511175B2Mar 31, 2009
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB18 citations92
US7365093B2Apr 29, 2008
Endothelin antagonists
ABBOTT LAB18 citations92
US7217838B2May 15, 2007
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB26 citations92
US6946481B1Sep 20, 2005
Endothelin antagonists
ABBOTT LAB37 citations92
US6462194B1Oct 8, 2002
Endothelin antagonists
ABBOTT LAB14 citations92
US6124341ASep 26, 2000
Endothelin antagonists
ABBOTT LAB21 citations92
US5622971AApr 22, 1997
Endothelin antagonists
ABBOTT LAB25 citations92
US7880001B2Feb 1, 2011
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
ABBOTT LAB9 citations83
US6380241B1Apr 30, 2002
Treatment of diseases using endothelin antagonists
ABBOTT LAB13 citations82
US5731434AMar 24, 1998
Endothelin antagonists
ABBOTT LAB15 citations82
US7528282B2May 5, 2009
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB7 citations73
USRE41135EFeb 16, 2010
Inhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB0 citations51
US8354422B2Jan 15, 2013
Pyrimidine inhibitors of kinase activity
ABBOTT LAB2 citations50
US8372841B2Feb 12, 2013
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB0 citations40
BITNER R SCOTT
5 patentsUS8993632B2Mar 31, 2015
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8716345B2May 6, 2014
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8415354B2Apr 9, 2013
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT1 citations48
US8198331B2Jun 12, 2012
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8940902B2Jan 27, 2015
Treatment of central nervous system disorders
BITNER R SCOTT0 citations47
ABBVIE INC
4 patentsUS9290444B2Mar 22, 2016
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBVIE INC0 citations50
US9133145B2Sep 15, 2015
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBVIE INC0 citations49
US9464072B2Oct 11, 2016
Treatment of central nervous system disorders
ABBVIE INC0 citations48
US10093624B2Oct 9, 2018
NAMPT and ROCK inhibitors
ABBVIE INC0 citations46